Ultragenyx to Participate at Investor Conferences in March
February 24, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update
February 06, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 20, 2024 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 20, 2024 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FASTs 17th Annual Global Science Summit
November 09, 2024 10:30 ET | Source: Ultragenyx Pharmaceutical Inc. Phase 1/2…